Skip to product information
1 of 1
IHC of Cyclin E1 on a FFPE Breast Carcinoma Tissue

Cyclin E1 (EP126)

US
IVD-CE
Europe
IVD-CE
International
IVD-CE
Size
Contact for price View full details

Product Information

Summary & Explanation

{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"Cyclin E1 forms a complex with and functions as a regulatory subunit of CDK2, whose activity is required for cell cycle G1/S transition phase of the cell cycle that determines cell division. The Cyclin E/CDK2 complex phosphorylates p27Kip1 (an inhibitor of Cyclin D), tagging it for degradation and thus promoting expression of Cyclin A, allowing progression to the S phase. This protein accumulates at the G1-S phase boundary and is degraded as cells progress through S phase. Apart from the function in cell cycle progression, cyclin E/CDK2 plays a role in the centrosome cycle by phosphorylating nucleophosmin (NPM). NPM is then released from binding to an unduplicated centrosome, thereby triggering duplication. Cyclin E/CDK2 has also been shown to regulate the apoptotic response to DNA damage via phosphorylation of FOXO1."}]},{"type":"paragraph","children":[{"type":"text","value":"Overexpression of Cyclin E correlates with tumorigenesis. It is involved in various types of cancers, including breast, colon, bladder, skin, and lung cancer."}]}]}

Antibody Type

Rabbit Monoclonal

Clone

EP126

Isotype

IgG

Localization

Nuclear

Dilution

1:50-1:200

Species Reactivity

Human

Immunogen

Synthetic peptide corresponding to residues of human Cyclin E1 protein.